ImmunityBio

NCT03563170

Phase 1/2Withdrawn20180 people20 Jun 2018clinicaltrials.gov

NCT03554109

Phase 2Withdrawn20180 people12 Jun 2018clinicaltrials.gov

NCT03520686

Phase 3Terminated2018102 people11 May 2018clinicaltrials.gov

NCT03387085

Phase 1/2Terminated20189 people29 Dec 2017clinicaltrials.gov

NCT03175666

Phase 1/2Withdrawn20170 people5 Jun 2017clinicaltrials.gov

NCT03169764

Phase 1/2Withdrawn20170 people30 May 2017clinicaltrials.gov

NCT03167177

Phase 1/2Withdrawn20170 people25 May 2017clinicaltrials.gov

NCT03167164

Phase 1/2Withdrawn20170 people25 May 2017clinicaltrials.gov

NCT02049905

Phase 3Completed2014433 people30 Jan 2014clinicaltrials.gov

NCT01514188

Phase 2Completed2012126 people23 Jan 2012clinicaltrials.gov